- Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis
-
Poznyak AV, Sukhorukov VN, Popov MA, Chegodaev YS, Postnov AY, Orekhov AN
- KMID: 2546556
- J Lipid Atheroscler.
- 2023 Sep;12(3):223-236.
- doi: 10.12997/jla.2023.12.3.223
The proteins of the Wnt family are involved in a variety of physiological processes by means of several canonical and noncanonical signaling pathways. Wnt signaling has been recently identified as... -
- CITED
-
- Close
- SHARE
-
- Close
- Vegetarian Diet for Cardiovascular Disease Risk Reduction: Cons
-
Han SN
- KMID: 2546564
- J Lipid Atheroscler.
- 2023 Sep;12(3):323-328.
- doi: 10.12997/jla.2023.12.3.323
Numerous studies have reported that adopting a plant-based diet can significantly reduce the risk of cardiovascular diseases (CVDs). Not only does a vegetarian diet help mitigate the risk of these... -
- CITED
-
- Close
- SHARE
-
- Close
- Vegetarian Diets and Cardiovascular Risk Reduction: Pros
-
Lee SY
- KMID: 2546563
- J Lipid Atheroscler.
- 2023 Sep;12(3):315-322.
- doi: 10.12997/jla.2023.12.3.315
There is an ongoing need for public health interventions aimed at further mitigating the risk of cardiovascular disease (CVD) through changes in dietary patterns and other lifestyle habits. Plant-based diets... -
- CITED
-
- Close
- SHARE
-
- Close
- Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats
-
Sundararajan S, Jayachandran I, Pandey GK, Venkatesan S, Rajagopal A, Gokulakrishnan K, Balasubramanyam M, Mohan V, Manickam N
- KMID: 2546561
- J Lipid Atheroscler.
- 2023 Sep;12(3):290-306.
- doi: 10.12997/jla.2023.12.3.290
Objective: In previous research, we found that Sestrin2 has a strong association with plasma atherogenicity and combats the progression of atherogenesis by regulating the AMPK-mTOR pathway. Metformin, an activator of... -
- CITED
-
- Close
- SHARE
-
- Close
- Dyslipidemia Fact Sheet in South Korea, 2022
-
Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, Shin MJ, Jin HY, Moon J, Lee H, Kim HC, Jeong IK, on behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis
- KMID: 2546557
- J Lipid Atheroscler.
- 2023 Sep;12(3):237-251.
- doi: 10.12997/jla.2023.12.3.237
Objective: This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing the Practical Differences in LDL-C Estimates Calculated by Friedewald, Martin/Hopkins, or NIH Equation 2: An Observation CrossSectional Study
-
Wang I, Rahman MH, Hou S, Lin HW
- KMID: 2546558
- J Lipid Atheroscler.
- 2023 Sep;12(3):252-266.
- doi: 10.12997/jla.2023.12.3.252
Objective: Low-density lipoprotein-cholesterol (LDL-C) remains a clinically important cholesterol target in primary prevention of atherosclerotic cardiovascular disease. The present study aimed to assess the practical differences among three equations utilized... -
- CITED
-
- Close
- SHARE
-
- Close
- The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
-
Cho YK, Lee YL, Jung CH
- KMID: 2546555
- J Lipid Atheroscler.
- 2023 Sep;12(3):213-222.
- doi: 10.12997/jla.2023.12.3.213
Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings. For the treatment of peptide-secreting enteroendocrine cells, most... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid-Lowering Efficacy of Combination Therapy With ModerateIntensity Statin and Ezetimibe Versus High-Intensity Statin Monotherapy: A Randomized, Open-Label, NonInferiority Trial From Korea
-
Choi H, Kang SH, Jeong SW, Yoon CH, Youn TJ, Song WH, Jeon DW, Lim SW, Lee JH, Cho SW, Chae IH, Kim CH
- KMID: 2546560
- J Lipid Atheroscler.
- 2023 Sep;12(3):277-289.
- doi: 10.12997/jla.2023.12.3.277
Objective: This phase IV, multicenter, randomized controlled, open-label, and parallel clinical trial aimed to compare the efficacy and safety of ezetimibe and moderate intensity rosuvastatin combination therapy to that of... -
- CITED
-
- Close
- SHARE
-
- Close
- Public Awareness of Dyslipidemia Among the Korean Population: A Survey Study
-
Bae JH, Jin ES, Kim SE, Kang S, Lee JY, Kim M, Jin HY, Shin MJ, Jeong IK, the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis
- KMID: 2546562
- J Lipid Atheroscler.
- 2023 Sep;12(3):307-314.
- doi: 10.12997/jla.2023.12.3.307
Objective: We aimed to assess the level of public awareness regarding dyslipidemia and its management among the Korean population. Methods: We conducted a web- or mobile-based survey study targeting the general... -
- CITED
-
- Close
- SHARE
-
- Close
- Elevated Lipoprotein(a) Levels and Atrial Fibrillation: A Systematic Review
-
Masson W, Barbagelata L, Nogueira JP, Corral P, Lavalle-Cobo A, Romeo FJ
- KMID: 2546559
- J Lipid Atheroscler.
- 2023 Sep;12(3):267-276.
- doi: 10.12997/jla.2023.12.3.267
Objective: The role of lipoprotein(a) (Lp[a]) as a possibly causal risk factor for atherosclerotic cardiovascular disease has been well established. However, the clinical evidence regarding the association between Lp(a) levels... -
- CITED
-
- Close
- SHARE
-
- Close
